Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC413

tezepelumab

  • Status:
    Veitt
  • Application date:
    12.12.2022
  • Application published:
    15.1.2023
  • Grant published:
    15.9.2024
  • Max expiry date:
    8.9.2028
  • Medicine name:
    TEZSPIRE
  • Medicine for children:
    No

Timeline

Today
12.12.2022Application
15.1.2023Publication
15.9.2024Registration
8.9.2028Expires

Marketing license

  • IS authorization number:
    EU/1/22/1677
  • Date:
    12.10.2022
  • Foreign authorization number:
    EU/1/22/1677
  • Date:
    13.6.2022

Owner

  • Name:
    AMGEN INC.
  • Address:
    One Amgen Center Drive, Thousand Oaks US

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, fyrsti

Deadline until: 14.03.2023

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 16.09.2024

Upload documents